Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Casale

Showing results (1-10 of 382) with videos related to

Pageof 39
Sort By:
The Journal of Allergy and Clinical Immunology|November 20, 2024
Omalizumab: The journey of the first anti-IgE approved for asthma and allergic disordersThomas B Casale
American Journal of Respiratory and Critical Care Medicine|November 13, 2001
Anti-immunoglobulin E (omalizumab) therapy in seasonal allergic rhinitisT B Casale
The Journal of Allergy and Clinical Immunology|September 30, 2022
Novel biologics for treatment of chronic spontaneous urticariaThomas B Casale
The American Review of Respiratory Disease|April 1, 1993
Acute effects of in vitro mast cell degranulation on human lung muscarinic receptorsT B Casale
The Journal of Allergy and Clinical Immunology|July 1, 1991
Neuropeptides and the lungT B Casale
Drugs of Today (Barcelona, Spain : 1998)|June 11, 2004
Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitisThomas B Casale,
The Journal of Allergy and Clinical Immunology|June 23, 2004
Status of immunotherapy: current and futureThomas B Casale
The Journal of Allergy and Clinical Immunology|April 1, 1989
The interaction of azelastine with human lung histamine H1, beta, and muscarinic receptor-binding sitesT B Casale
Postgraduate Medicine|August 12, 2009
Small airway inflammation: a new therapeutic target in asthma. IntroductionThomas B Casale
Postgraduate Medicine|August 12, 2009
The pathophysiology of small airway inflammation in asthmaThomas B Casale
Pageof 39

Showing results (1-10 of 382) with videos related to

Sort By:
Pageof 39
The Journal of Allergy and Clinical Immunology|November 20, 2024
Omalizumab: The journey of the first anti-IgE approved for asthma and allergic disordersThomas B Casale
American Journal of Respiratory and Critical Care Medicine|November 13, 2001
Anti-immunoglobulin E (omalizumab) therapy in seasonal allergic rhinitisT B Casale
The Journal of Allergy and Clinical Immunology|September 30, 2022
Novel biologics for treatment of chronic spontaneous urticariaThomas B Casale
The American Review of Respiratory Disease|April 1, 1993
Acute effects of in vitro mast cell degranulation on human lung muscarinic receptorsT B Casale
The Journal of Allergy and Clinical Immunology|July 1, 1991
Neuropeptides and the lungT B Casale
Drugs of Today (Barcelona, Spain : 1998)|June 11, 2004
Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitisThomas B Casale,
The Journal of Allergy and Clinical Immunology|June 23, 2004
Status of immunotherapy: current and futureThomas B Casale
The Journal of Allergy and Clinical Immunology|April 1, 1989
The interaction of azelastine with human lung histamine H1, beta, and muscarinic receptor-binding sitesT B Casale
Postgraduate Medicine|August 12, 2009
Small airway inflammation: a new therapeutic target in asthma. IntroductionThomas B Casale
Postgraduate Medicine|August 12, 2009
The pathophysiology of small airway inflammation in asthmaThomas B Casale
Pageof 39